Zhejiang Hisun Pharmaceutical (600267.SH) releases a forecasted profit, estimating a net profit of 570-630 million yuan in 2024, turning losses into profits.

19:02 22/01/2025

Guangzhou Pharmaceuticals Corporation (stock code: 600267.SH) announced that the company is expected to achieve attributable net profit to shareholders of the listed company for the year 2024...

Zhejiang Hisun Pharmaceutical (600267.SH) announced that the company expects to achieve a net profit attributable to shareholders of the listed company of 570 million to 630 million yuan in 2024, compared to a loss in the same period last year.

DL HOLDINGS GP (01709) spent HK$5.1021 million on 20th March to repurchase 3,970,000 shares.

QINIU (02567) announced its performance in 2025, achieving revenue of approximately 1.769 billion yuan, a year-on-year increase of 23.1%.

SOLIS HOLDINGS (02227) acquires a bond worth 1 million Singapore dollars.

DL HOLDINGS GP (01709) spent HK$5.1021 million on 20th March to repurchase 3,970,000 shares.

QINIU (02567) announced its performance in 2025, achieving revenue of approximately 1.769 billion yuan, a year-on-year increase of 23.1%.

SOLIS HOLDINGS (02227) acquires a bond worth 1 million Singapore dollars.